A bipartisan group of senators sent a letter to HHS asking it to rethink its appeal of a recent federal district court decision that limits the use of “copay accumulators" — which are programs insurers use to prevent medication copay assistance from counting toward patients’ deductibles or out-of-pocket maximums.
Medicine Cabinet, a new solution by GoodRx, gives users reminders to take their medications and refill prescriptions and recommends pharmacies based on prescription costs. It also has a rewards system for using GoodRx coupons and picking up prescriptions on time.
What we need to overcome adherence challenges is a digitally enabled marketplace of options that can be personalized to the patient and the context of their specific condition, pharmacy preference and ability to pay.
There is a huge opportunity for PBMs and health systems to use AI to help address the challenges surrounding the affordability and accessibility of medicines, from navigating formularies to resolving prior authorization. More automation in pharmacies and with ordering workflows is one piece of that puzzle.
Mail order pharmacies like Mark Cuban Cost Plus Drug Company and Amazon's RxPass are gaining popularity. But they're missing in-depth consultations with pharmacists. Aspen RxHealth is trying to fill this gap and sees itself as a potential partner for mail order pharmacies.
Scene Health's $17.7 million Series B funding round was led by ABS Capital Partners and includes participation from Claritas Health Ventures, PTX Capital, Kapor Capital and Healthworx, the investment arm of CareFirst BlueCross BlueShield. Since Scene Health was founded in 2014, it has raised more than $25 million total.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Arrive Health (formerly RxRevu) recently acquired a suite of technology developed at UPMC. The technology suite includes an AI-powered chatbot and customer relationship management platform, both designed to support improved medication adherence and prescription capture rates.
Connecting vital, underutilized services like medication reviews to the daily lives and routines of older adults is the logical next step in the movement of care to the home
The problem with the US healthcare system is one of misaligned incentives. Prescribers are paid to evaluate patients and to administer care. All prescribers want the best outcomes for their patients, but the system does not incentivize choosing the best medications to promote those outcomes. Instead it is incentivized to pay for only the medications prescribed.
When pharmacies engage on a human level with patient support programs, patients become more fully engaged in their treatment, leading to potentially significant health benefits and good business for pharmacies.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Integrating advanced technologies, including smart packaging and powerful data analytics, is driving a revolution in adherence monitoring that is accelerating drug development timelines, lowering clinical research costs and making trials safer for participants.
A report from CoverMyMeds interviewed 1000 patients, doctors, and pharmacists and data indicated a further shift towards digital health, challenges in affording medications, and additional roles taken on by pharmacists.
The conversation about medication shouldn’t end when the prescription is written. Physicians need to be accessible to patients to talk about how the medication is working for them, how often they are using it as prescribed, and what barriers they have to using it.
Reliable, real-time prescription decision support technology empower the entire care team to work seamlessly to help people get the medicine they need — and stay on therapy.
Investing in patient engagement strategies that facilitate enrollment and keep people on board, on track, and on drug could be the answer developers have been looking for.
